Ellen L Burnham1, Robert C Hyzy2, Robert Paine3, Aine M Kelly4, Leslie E Quint4, David Lynch5, Douglas Curran-Everett6, Marc Moss7, Theodore J Standiford2. 1. From the Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO. Electronic address: ellen.burnham@ucdenver.edu. 2. Division of Pulmonary and Critical Care Medicine, University of Michigan School of Medicine, Ann Arbor, MI. 3. Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT. 4. Department of Medicine, and the Department of Radiology, University of Michigan School of Medicine, Ann Arbor, MI. 5. Department of RadiologyNational Jewish Health, Denver, CO. 6. Department of Biostatistics and Bioinformatics, National Jewish Health, Denver, CO; Department of Biostatistics and Informatics, University of Colorado School of Public Health, Aurora, CO. 7. From the Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO.
Abstract
BACKGROUND: In ARDS, the extent of fibroproliferative activity on chest high-resolution CT (HRCT) scan has been reported to correlate with poorer short-term outcomes and pulmonary-associated quality of life. However, clinical factors associated with HRCT scan fibroproliferation are incompletely characterized. We questioned if lung compliance assessed at the bedside would be associated with fibroproliferation on HRCT scans obtained during the resolution phase of ARDS. METHODS: We used data from a published randomized, controlled clinical trial in ARDS. All patients were cared for using a low tidal volume strategy. Demographic data and ventilator parameters were examined in association with radiologic scores from chest HRCT scans obtained 14 days after diagnosis. RESULTS: Data from 82 patients with ARDS were analyzed. Average static respiratory compliance over the first 14 days after diagnosis was inversely associated with chest HRCT scan reticulation (ρ = -0.46); this relationship persisted in multivariable analysis including APACHE (Acute Physiology and Chronic Health Evaluation) II scores, initial Pao2/Fio2, pneumonia diagnosis, and ventilator days. Average static respiratory compliance was also lower among patients with bronchiectasis at day 14 (P = .007). Initial static respiratory compliance obtained within the first day after ARDS diagnosis was correlated inversely with the presence of HRCT scan reticulation (ρ = -0.38) and was lower among patients who demonstrated bronchiectasis on the day 14 HRCT scan (P = .008). CONCLUSIONS: In patients with ARDS, diminished lung compliance measured bedside was associated with radiologic fibroproliferation 14 days post diagnosis. Establishing factors that predispose to development of excessive fibroproliferation with subsequent confirmation by chest HRCT scan represents a promising strategy to identify patients with ARDS at risk for poorer clinical outcomes.
RCT Entities:
BACKGROUND: In ARDS, the extent of fibroproliferative activity on chest high-resolution CT (HRCT) scan has been reported to correlate with poorer short-term outcomes and pulmonary-associated quality of life. However, clinical factors associated with HRCT scan fibroproliferation are incompletely characterized. We questioned if lung compliance assessed at the bedside would be associated with fibroproliferation on HRCT scans obtained during the resolution phase of ARDS. METHODS: We used data from a published randomized, controlled clinical trial in ARDS. All patients were cared for using a low tidal volume strategy. Demographic data and ventilator parameters were examined in association with radiologic scores from chest HRCT scans obtained 14 days after diagnosis. RESULTS: Data from 82 patients with ARDS were analyzed. Average static respiratory compliance over the first 14 days after diagnosis was inversely associated with chest HRCT scan reticulation (ρ = -0.46); this relationship persisted in multivariable analysis including APACHE (Acute Physiology and Chronic Health Evaluation) II scores, initial Pao2/Fio2, pneumonia diagnosis, and ventilator days. Average static respiratory compliance was also lower among patients with bronchiectasis at day 14 (P = .007). Initial static respiratory compliance obtained within the first day after ARDS diagnosis was correlated inversely with the presence of HRCT scan reticulation (ρ = -0.38) and was lower among patients who demonstrated bronchiectasis on the day 14 HRCT scan (P = .008). CONCLUSIONS: In patients with ARDS, diminished lung compliance measured bedside was associated with radiologic fibroproliferation 14 days post diagnosis. Establishing factors that predispose to development of excessive fibroproliferation with subsequent confirmation by chest HRCT scan represents a promising strategy to identify patients with ARDS at risk for poorer clinical outcomes.
Authors: S Crotti; D Mascheroni; P Caironi; P Pelosi; G Ronzoni; M Mondino; J J Marini; L Gattinoni Journal: Am J Respir Crit Care Med Date: 2001-07-01 Impact factor: 21.405
Authors: G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg Journal: Am J Respir Crit Care Med Date: 1994-03 Impact factor: 21.405
Authors: Nuria E Cabrera-Benítez; Matteo Parotto; Martin Post; Bing Han; Peter M Spieth; Wei-Erh Cheng; Francisco Valladares; Jesús Villar; Mingayo Liu; Masaaki Sato; Haibo Zhang; Arthur S Slutsky Journal: Crit Care Med Date: 2012-02 Impact factor: 7.598
Authors: Matthias Briel; Maureen Meade; Alain Mercat; Roy G Brower; Daniel Talmor; Stephen D Walter; Arthur S Slutsky; Eleanor Pullenayegum; Qi Zhou; Deborah Cook; Laurent Brochard; Jean-Christophe M Richard; Francois Lamontagne; Neera Bhatnagar; Thomas E Stewart; Gordon Guyatt Journal: JAMA Date: 2010-03-03 Impact factor: 56.272
Authors: Jan Hirsch; Kirk C Hansen; Anil Sapru; James A Frank; Robert J Chalkley; Xiaohui Fang; Jonathan C Trinidad; Peter Baker; Alma L Burlingame; Michael A Matthay Journal: Am J Respir Crit Care Med Date: 2007-03-15 Impact factor: 21.405
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Luis G Vargas Buonfiglio; Mosaab Bagegni; Jennifer A Borcherding; Jessica C Sieren; Juan C Caraballo; Andrew Reger; Joseph Zabner; Xiaopeng Li; Alejandro P Comellas Journal: Am J Respir Cell Mol Biol Date: 2016-12 Impact factor: 6.914
Authors: L Bitker; F Dhelft; L Chauvelot; E Frobert; L Folliet; M Mezidi; S Trouillet-Assant; A Belot; B Lina; F Wallet; J C Richard Journal: Ann Intensive Care Date: 2020-12-10 Impact factor: 6.925
Authors: K Martini; A R Larici; M P Revel; B Ghaye; N Sverzellati; A P Parkar; A Snoeckx; N Screaton; J Biederer; H Prosch; M Silva; A Brady; F Gleeson; T Frauenfelder Journal: Eur Radiol Date: 2021-10-29 Impact factor: 7.034
Authors: Christine M Lin; Abdullah Alrbiaan; John Odackal; Zhimin Zhang; Yogesh Scindia; Sun-Sang J Sung; Marie D Burdick; Borna Mehrad Journal: Mol Med Date: 2020-05-27 Impact factor: 6.354
Authors: M Peiro Chamarro; P Ruiz de Gopegui Miguelena; I Sampedro Martín; A Callau Calvo; M T Martínez Lamazares; C Fuertes Schott Journal: Med Intensiva (Engl Ed) Date: 2020-07-11